VEGFA and neoplasm: Because our protocol incorporates this bias against finding a difference between rapamycin treated and combination treated groups by excluding measurements of tumor volumes beyond ~3000 mm3 (when mice must be euthanized), the data presented here suggest that further study into VEGF inhibitors in combination with rapamycin is warranted.